Tricuspid Regurgitation clinical trials at UCSF
1 research study open to eligible people
Tricuspid regurgitation is a heart condition where blood flows backwards instead of forward. There is a clinical trial at UCSF recruiting patients with severe tricuspid regurgitation to test a new repair system called Edwards PASCAL Transcatheter Repair System. The trial is for patients who are deemed high-risk for surgery.
Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
open to eligible people ages 18 years and up
To establish the safety and effectiveness of the Edwards PASCAL Transcatheter Repair System in patients with symptomatic severe tricuspid regurgitation who have been determined to be at an intermediate or greater estimated risk of mortality with tricuspid valve surgery by the cardiac surgeon with concurrence by the local Heart Team
San Francisco, California and other locations
Our lead scientists for Tricuspid Regurgitation research studies include Sammy Elmariah, MD.